Dolby Laboratories (DLB) FY2019 results: revenue $1.2 billion, up 17.7% on the year
Dolby Laboratories, Inc. (DLB) reported revenue of $1.2 billion for fiscal 2019, the year ended 27 September 2019, up 17.7% on the year before. Net income was $255 million, up 511.2%, and diluted earnings per share $2.44. The figures are the company's own, from the 10-K it filed with the SEC on 25 November 2019.
Revenue
$1.2 billion
+17.7% on the year
FY2012FY2019
Operating margin
20.7%
17.4% a year earlier
FY2012FY2019
Net income
$255 million
+511.2% on the year
FY2012FY2019
Diluted EPS
$2.44
+525.6% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
1,242
1,055
1,081
+17.7%
Cost of revenue
161
128
118
+26.1%
Gross profit
1,081
927
963
+16.6%
Gross margin
87.0%
87.9%
89.1%
Research and development
238
237
233
+0.5%
Operating income
257
184
247
+40.1%
Operating margin
20.7%
17.4%
22.9%
Interest expense
0.2
0.2
0.1
-14.1%
Pre-tax income
282
196
255
+43.8%
Income tax
26.8
154
48.0
-82.6%
Effective tax rate
9.5%
78.5%
18.8%
Net income
255
41.7
206
+511.2%
Net margin
20.5%
4.0%
19.1%
Diluted EPS
$2.44
$0.39
$2.00
+525.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
328
352
378
-7.0%
Capital expenditure
96.3
72.8
99.6
+32.2%
Free cash flow
231
279
278
-17.2%
Free cash flow margin
18.6%
26.5%
25.7%
Cash from investing
-56.2
78.1
-158
Cash from financing
-385
-134
-107
Depreciation and amortisation
85.1
81.3
84.3
+4.7%
Share-based compensation
76.6
71.2
65.3
+7.5%
Buybacks
341
150
100
+126.3%
Dividends paid
77.5
66.2
57.1
+17.1%
Dividend per share
$0.79
$0.67
$0.58
+17.9%
Diluted shares, weighted
105m
107m
103m
-2.2%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
2,307
2,364
2,137
-2.4%
Non-controlling interest
5.7
6.6
7.1
-13.5%
Debt
0.0
0.0
0.0
Operating lease liabilities
0.0
n/a
n/a
Other liabilities
509
495
390
+2.8%
Total liabilities and equity
2,822
2,865
2,534
-1.5%
Fixed assets
537
514
485
+4.5%
Goodwill
335
328
311
+2.1%
Intangible assets
181
184
190
-1.7%
Investments
299
366
562
-18.4%
Cash and equivalents
797
918
634
-13.2%
Receivables
189
166
73.8
+13.8%
Inventory
32.3
26.2
25.1
+23.4%
Other assets
451
363
252
+24.3%
Total assets
2,822
2,865
2,534
-1.5%
10-K for the year ended 27 September 2019, filed 25 November 2019: the filing.